ArticleScience progress
Diffusion model-based contrast-enhanced CT synthesis for breast cancer radiotherapy: Pursuing contrast-free imaging.
Article in Science progress. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectiveThe purpose of this study aims to develop a novel deep learning framework for exploring its application effect in the transition from non-contrast computed tomography (NCCT) to contrast-enhanced computed tomography (CECT) in breast cancer radiotherapy.Materials and methodsA total of 194 patients with a pair of NCCT and CECT including 176 patients from hospital one and 18 patients from hospital two were enrolled in this study which were divided into training cohort (122 patients), internal testing cohort (54 patients) and external validation cohort (18 patients). Pix2Pix, CycleGAN, RegGAN and SynDiff were used to develop image-to-image translation in this study. PSNR, SSIM and NMAE were applied to evaluate the performance of automatic models by comparing them with original in the three cohorts.ResultsThe SynDiff models achieved the highest PSNR values of 28.56 and 26.97 dB, the highest SSIM value of 0.943 and 0.940, the lowest NMAE value of 0.011 and 0.012 compared with Pix2Pix, CycleGan and RegGAN in the internal validation cohorts and external validation cohorts, respectively. The p-values of the Wilcoxon signed-rank test for the SynDiff model compared with the other three models in PSNR and NMAE were all less than 0.05 in the internal and external validation cohorts. The p-values of the Wilcoxon signed-rank test for the SynDiff model compared with the other three models in PSNR and NMAE were all less than 0.05 in the internal and external validation cohorts. The p-values of the Wilcoxon signed-rank test for the SynDiff model compared with Pix2Pix and CycleGAN in SSIM were all less than 0.05 and compared with RegGAN in SSIM were 0.091 in the internal validation cohorts and all less than 0.05 in the external cohorts.ConclusionSynDiff is a promising method to explore its application effect in the transition from NCCT to CECT in the breast-cancer radiotherapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.